Nasdaq3d
PSTV Stock Surges as FDA Accepts Proprietary Name for Lead Drug
Earlier this month, the FDA granted an Orphan Drug Designation ... acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed ...
Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025
We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at ...
Nasdaq3d
Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy
The FDA’s latest nod makes Amvuttra the first ... We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed ...
Nasdaq3d
FDA Approves Novartis Drug for Rare Kidney Disease Treatment
Fabhalta obtained FDA and European Commission (EC ... get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions ...
Nasdaq5d
Liquidia Corporation Advances YUTREPIA™ Towards Final FDA Approval While Strengthening Financial Position by Up to $100 Million
YUTREPIA received tentative FDA approval for treating pulmonary arterial ... Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with ...
Nasdaq5d
FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review
Image Source: Zacks Investment Research Contingent upon the FDA’s approval ... delivering an average surprise of 19.47%. 7 Best Stocks for the Next 30 Days Just released: Experts distill ...
Nasdaq11d
Tempest Therapeutics Receives FDA Approval to Advance Phase 2 Trial of TPST-1495 for Familial Adenomatous Polyposis
Tempest Therapeutics, Inc. has announced that the U.S. FDA has granted a "Study May Proceed" letter for their Phase 2 clinical trial of TPST-1495, a novel dual receptor inhibitor aimed at treating ...
Nasdaq6d
Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
Such investigational drug has not yet been approved by the FDA. Pnina Fishman, CSO & Chairperson of Can-Fite BioPharma, commented: “We are pleased to offer this compassionate use program with ...
Nasdaq3d
Glenmark Gets FDA Approval For Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
The FDA has determined it to be bioequivalent to ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Nasdaq10d
ANI Pharmaceuticals Receives FDA Approval for Expanded ILUVIEN Indication to Treat Chronic Non-Infectious Uveitis
March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ...
Nasdaq11d
Lifeward Ltd. Announces FDA Clearance for ReWalk 7 Exoskeleton Device
Lifeward received 510(k) FDA clearance for the ReWalk 7 ... 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical ...
Nasdaq7d
Travere Therapeutics Submits sNDA for FILSPARI as Potential First FDA-Approved Treatment for FSGS
Inc., (Nasdaq: TVTX) today announced the Company has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking priority review for traditional ...